Medical Condition News

RSS

RXi to present updated NeuVax Phase II trial data in breast cancer at ASCO 2011

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, will be presenting data from the NeuVax Phase II adjuvant breast cancer clinical trial at the 2011 annual meeting of The American Society of Clinical Oncology in Chicago.

19 May 2011

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Repligen Corporation announced today that it has received approval from the Food and Drug Administration to initiate a Phase 1 clinical trial of RG3039, a potential treatment for Spinal Muscular Atrophy.

19 May 2011

Online program helps people to manage chronic pain

There is good news for the 76 million Americans who experience chronic pain including migraine, back pain, fibromyalgia and arthritis. A new study reveals that an online, self-paced chronic pain management program reduces the physical and psychological burdens of this debilitating condition.

19 May 2011

Isis receives $5M milestone payment from GSK for initiating ISIS-TTRRx Phase 1 study

Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the initiation of a Phase 1 clinical study for ISIS-TTRRx.

19 May 2011

Omeros advances OMS103HP and OMS302 into Phase 3 clinical programs

Omeros Corporation today announced that it is advancing two of its product candidates from its PharmacoSurgery platform – OMS103HP for arthroscopic meniscectomy and OMS302 for intra-ocular lens replacement surgery – into Phase 3 clinical development programs.

19 May 2011

Caring Online offers comprehensive and informative website on adult eating disorders

Are you aware that eating disorders affect more than 10 million people in this country, and that bulimia, anorexia, binge eating and other destructive food behaviors are not exclusive to the youth? These serious and often deadly afflictions have become a growing problem with midlife adults and older, often more difficult to detect as adults are expected to have it "all together."

19 May 2011

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Use of a simple, at-home screening test by Canadians can prevent many unnecessary colorectal cancer deaths, according to a special report about colorectal cancer in Canadian Cancer Statistics 2011 released today by the Canadian Cancer Society, in collaboration with the Public Health Agency of Canada and Statistics Canada.

19 May 2011

Affymetrix launches new Axiom myDesign TG Arrays for targeted genotyping market

Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.

19 May 2011

Experts to develop pioneering tool for personalised asthma and COPD therapy

A team of international experts, led by a University of Leicester researcher based at Glenfield Hospital, is set to develop a pioneering tool to help tailor the treatment of asthma and chronic obstructive pulmonary disease as part of a new EU project.

19 May 2011

Dementia experts call for new approach to support patients and carers

Dementia experts call for a new approach to supporting dementia patients and their carers, after identifying gaps in current health and social care provision. The findings are highlighted in a new report, written by a panel of some of England's leading experts in dementia care, launched in the House of Lords today.

19 May 2011

Medtronic issues statement on results of CoreValve System clinical data presented at EuroPCR 2011

Medtronic, Inc. today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve System, delivered through a new approach beneath the collarbone, achieved excellent procedural success rates and low in-hospital complication rates.

From Medtronic 19 May 2011

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells - also known as "suppressor cells." The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods. Historically, regulatory T-cells have been difficult to replicate.

19 May 2011

Low calorie sweeteners offer effective solution to manage weight

The desire to eat sweet things does not need to be suppressed, just managed, according to health and nutrition experts meeting at the International Sweeteners Association's conference in Brussels today.

19 May 2011

Sensitive troponin assays improve clinical outcome and cardiac patient management

Research presented this week at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical outcomes and patient survival in patients with suspected acute coronary syndromes.

19 May 2011

TissueGene commences enrollment in TG-C Phase II trial for severe knee osteoarthritis

TissueGene, Inc. announced today that it has initiated patient enrollment for a U.S. Phase II clinical trial of its lead product candidate TG-C. TG-C involves human allogeneic chondrocytes developed to produce the therapeutic protein TGF-beta1 for the regeneration of cartilage in patients suffering from severe osteoarthritis of the knee.

19 May 2011

USPTO grants four key patents for Alvine's proteases to detect celiac disease

Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the United States Patent and Trademark Office has issued four key patents: 7,943,312; 7,928,056; 7,923,532; and 7,910,541, protecting various aspects of Alvine's core technology.

19 May 2011

Synthetic nanopatch helps regenerate natural heart tissue cells

When you suffer a heart attack, a part of your heart dies. Nerve cells in the heart's wall and a special class of cells that spontaneously expand and contract - keeping the heart beating in perfect synchronicity - are lost forever. Surgeons can't repair the affected area. It's as if when confronted with a road riddled with potholes, you abandon what's there and build a new road instead.

19 May 2011

YM BioSciences announces updated interim results from CYT387 Phase I/II trial in myelofibrosis

YM BioSciences Inc., today reported updated interim results for the first 60 patients with high/intermediate-risk myelofibrosis who have completed a minimum of three cycles of treatment (12 weeks) in its ongoing Phase I/II multi-center study.

19 May 2011

Study: 10% of cancer patients fail to fill initial oral oncolytic prescriptions

Ten percent of cancer patients failed to fill their initial prescriptions for oral anti-cancer drugs, according to a new study published jointly today in the Journal of Oncology Practice and American Journal of Managed Care.

19 May 2011

Consumption of dairy products does not increase heart attack risk

Dairy products can be high in harmful saturated fat but not necessarily in risk to the heart. A newly published analysis of thousands of adults in Costa Rica found that their levels of dairy consumption had nothing to do statistically with their risk of a heart attack.

19 May 2011

Medical Condition News

RXi to present updated NeuVax Phase II trial data in breast cancer at ASCO 2011

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Online program helps people to manage chronic pain

Isis receives $5M milestone payment from GSK for initiating ISIS-TTRRx Phase 1 study

Omeros advances OMS103HP and OMS302 into Phase 3 clinical programs

Caring Online offers comprehensive and informative website on adult eating disorders

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Affymetrix launches new Axiom myDesign TG Arrays for targeted genotyping market

Experts to develop pioneering tool for personalised asthma and COPD therapy

Dementia experts call for new approach to support patients and carers

Medtronic issues statement on results of CoreValve System clinical data presented at EuroPCR 2011

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

Low calorie sweeteners offer effective solution to manage weight

Sensitive troponin assays improve clinical outcome and cardiac patient management

TissueGene commences enrollment in TG-C Phase II trial for severe knee osteoarthritis

USPTO grants four key patents for Alvine's proteases to detect celiac disease

Synthetic nanopatch helps regenerate natural heart tissue cells

YM BioSciences announces updated interim results from CYT387 Phase I/II trial in myelofibrosis

Study: 10% of cancer patients fail to fill initial oral oncolytic prescriptions

Consumption of dairy products does not increase heart attack risk

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News